AXLA Axcella Health

Axcella to Report Second Quarter 2020 Financial Results and Hold Conference Call on August 5, 2020

(Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced that it plans to report its second quarter financial results and other business updates on August 5, 2020. The company will host a conference call at 8:30 a.m. ET that morning.

The conference call webcast and accompanying slides will be made available shortly before the start of the call on the company’s website at in the Investors & News section. To access the call via telephone, please dial (866) 652-5200 (U.S. toll free) or (412) 317-6060 (international) five minutes prior to the start time. For those unable to listen in live, a webcast archive will be available on the company’s website for 30 days following the call.

Internet Posting of Information

Axcella uses its website, , as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Such disclosures will be included on the company’s website in the “Investors and News” section. Accordingly, investors should monitor such portions of the company’s website, in addition to following its press releases, SEC filings and public conference calls and webcasts.

About Axcella

Axcella is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health. The company’s product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. Axcella’s pipeline includes lead therapeutic candidates for non-alcoholic steatohepatitis (NASH) and the reduction in risk of overt hepatic encephalopathy (OHE) recurrence. Additional muscle- and blood-related programs are in earlier-stage development. For more information, please visit .

EN
03/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Axcella Health

Andreas Argyrides ... (+2)
  • Andreas Argyrides
  • Liana Moussatos
Andreas Argyrides ... (+8)
  • Andreas Argyrides
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Liana Moussatos
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
O5Q OWENS CORNING INC
BLUE BLUEBIRD BIO INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NVCR NOVOCURE LTD.
KPTI KARYOPHARM THERAPEUTICS
GERN GERON CORP.
FL FOOT LOCKER INC.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
VRNA VERONA PHARMA ADS
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
SURF SURFACE ONCOLOGY
UBX UNITY BIOTECHNOLOGY
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
ISEE IVERIC BIO
IMUX IMMUNIC INC
BCEL ATRECA
C TEST
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
KDNY CHINOOK THERAPEUTICS
PASG INC.
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
FRLN ADICET BIO INC
ITOS FREELINE THERAPEUTICS HOLDINGS ADS
INZY ITEOS THERAPEUTICS
CDAK INOZYME PHARMA
ZNTL CODIAK BIOSCIENCES
BEAM INC.
PRAX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX PRAXIS PRECISION MEDICINES
KNTE COGENT BIOSCIENCES INC
VRDN TRAVERE THERAPEUTICS INC
VOR KINNATE BIOPHARMA
DAWN VIRIDIAN THERAPEUTICS INC
ELEV VOR BIOPHARMA
FHTX DAY ONE BIOPHARMACEUTICALS INC
TNGX ELEVATION ONCOLOGY
LBPH FOGHORN THERAPEUTICS
THRX TANGO THERAPEUTICS
VERA INC
TSVT LONGBOARD PHARMACEUTICALS
IMPL THESEUS PHARMACEUTICALS
DSGN INC.
TCRR VERA THERAPEUTICS INC
ATXS 2SEVENTY BIO INC
RANI IMPEL NEUROPHARMA INC
AVTE DESIGN THERAPEUTICS INC
CMPX TCR2 THERAPEUTICS INC
KRTX ASTRIA THERAPEUTICS INC
FUSN RANI THERAPEUTICS HLDGS INC
VIGL AEROVATE THERAPEUTICS INC
EWTX COMPASS THERAPEUTICS
BOLD KARUNA THERAPEUTICS INC
FUSION PHARMACEUTICALS INC
VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC
AUDENTES THERAPEUTICS
Andreas Argyrides ... (+2)
  • Andreas Argyrides
  • Liana Moussatos
Wedbush Research
  • Wedbush Research
W WAYFAIR INC.
2454 MEDIATEK INC.
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
PMT PENNYMAC MORTGAGE INVESTMENT TRUST
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
RGNX REGENXBIO INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PCRX PACIRA BIOSCIENCES INC.
PB PROSPERITY BANCSHARES INC.(R)
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GERN GERON CORP.
EWBC EAST WEST BANCORP INC.
BPMC BLUEPRINT MEDICINES CORP.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
OSTK OVERSTOCK.COM INC.
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
NTLA INTELLIA THERAPEUTICS INC.
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
AX AXOS FINANCIAL INC.
YMAB Y-MABS THERAPEUTICS
IMUX IMMUNIC INC
DELL DELL TECHNOLOGIES INC CLASS C
AXLA AXCELLA HEALTH
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
AQST INC.
KDNY AQUESTIVE THERAPEUTICS
BDTX CHINOOK THERAPEUTICS
COGT INC.
KNTE BLACK DIAMOND THERAPEUTICS
CYT COGENT BIOSCIENCES INC
TNGX KINNATE BIOPHARMA
THRX CYTEIR THERAPEUTICS
MRVL INC
STX TANGO THERAPEUTICS
GFS INC
THESEUS PHARMACEUTICALS
INC.
MARVELL TECHNOLOGY INC
SEAGATE TECHNOLOGY HLDGS PLC
GLOBALFOUNDRIES INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch